Treatment adherence of cancer patients to orally administered chemotherapy: Insights from a Greek study using a self-reported questionnaire

Journal of Oncology Pharmacy Practice

Volumn 17, Issue 4, 2011, Pages 304-311

  Saratsiotou, Ioanna ^a   Kordoni, Maria ^b   Bakogiannis, Charalampos ^b   Livadarou, Eleftheria ^c   Skarlos, Dimosthenis ^c   Kosmidis, Paris A ^b   Razis, Evangelia ^b  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b HYGEIA HOSPITAL   (Greece)

^c Metropolitan Hospital   (Greece)

Author keywords

cancer treatment; Oral chemotherapy; patient adherence

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; ERLOTINIB; IBANDRONIC ACID; IMATINIB; LAPATINIB; NAVELBINE; SORAFENIB; SUNITINIB; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; TREATMENT REFUSAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; GREECE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF REPORT;

EID: 82555194260     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155210380292     Document Type: Article

References (11)

1. Ruddy K, Mayer E, Partridge A.. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009 ; 59: 56-66
2. Partridge AH, Avorn J, Wang PS, Winer EP.. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 ; 94: 652-661 (Pubitemid 34552485)
3. Osterberg L, Blaschke T.. Adherence to medication. N Engl J Med. 2005 ; 353: 487-497 (Pubitemid 41127293)
4. Partridge AH, Wang PS, Winer EP, Avorn J.. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 ; 21: 602-606 (Pubitemid 46621892)
5. Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol. 2010 ; 28: 2381-2388
6. Lee CR, Nicholson PW, Souhami RL, Deshmukh AA.. Patient compliance with oral chemotherapy as accessed by a novel electronic technique. J Clin Oncol. 1992 ; 10: 1007-1013
7. Kirk MC, Hudis CA.. Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer. 2008 ; 8: 155-161 (Pubitemid 351655930)
8. Andreis F, Rizzi A, Mosconi P, Braun C, Rota L, Meriggi F, et al. Quality of life in colon cancer patients with skin side effects: Preliminary results from a monocentric cross sectional study. Health Qual Life Outcomes. 2010 ; 8: 40-40
9. Crippa Marques PA, Geraldo Pierin AM.. Factors that affect cancer patient compliance to oral anti-neoplastic therapy. Acta Paul Enferm. 2008 ; 21: 323-329
10. Moore SRN.. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs. 2007 ; 30: 112-122
11. Findlay M, von Minckwitz G, Wardley A.. Effective oral chemotherapy for breast cancer: Pillars of strength. Ann Oncol. 2008 ; 19: 212-222 (Pubitemid 351201700)